Lipocalin-type prostaglandin D synthase/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid. - Wikidata - wikimedia - TriplyDB

Lipocalin-type prostaglandin D synthase/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid.

Lipocalin-type prostaglandin D synthase/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid.

http://www.wikidata.org/entity/Q35748577

about

De novo synthesis, uptake and proteolytic processing of lipocalin-type prostaglandin D synthase, beta-trace, in the kidneys Biological markers of amyloid beta-related mechanisms in Alzheimer's disease Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis Structural Basis of the Catalytic Mechanism Operating in Open-Closed Conformers of Lipocalin Type Prostaglandin D Synthase Chaperones of F1-ATPase High-resolution structures of mutants of residues that affect access to the ligand-binding cavity of human lipocalin-type prostaglandin D synthase The neuroendocrine protein 7B2 suppresses the aggregation of neurodegenerative disease-related proteins NMR solution structure of lipocalin-type prostaglandin D synthase: evidence for partial overlapping of catalytic pocket and retinoic acid-binding pocket within the central cavity Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease Lipocalin-type prostaglandin D synthase scavenges biliverdin in the cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage.Prostaglandin J2: a potential target for halting inflammation-induced neurodegeneration.Dexamethasone protects neonatal hypoxic-ischemic brain injury via L-PGDS-dependent PGD2-DP1-pERK signaling pathway.Serine protease HtrA1 accumulates in corneal transforming growth factor beta induced protein (TGFBIp) amyloid deposits Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration.Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.Lipocalin-type prostaglandin D2 synthase protein regulates glial cell migration and morphology through myristoylated alanine-rich C-kinase substrate: prostaglandin D2-independent effects Fibrinogen has chaperone-like activity.Targeted proteomics in Alzheimer's disease: focus on amyloid-beta.Plug-based microfluidics with defined surface chemistry to miniaturize and control aggregation of amyloidogenic peptides.The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease.Lipocalin-prostaglandin D synthase is a critical beneficial factor in transient and permanent focal cerebral ischemia.Biosensor-based label-free assays of amyloid growth.Therapeutic implications of the prostaglandin pathway in Alzheimer's disease.Association of lipocalin-type prostaglandin D synthase with disproportionately enlarged subarachnoid-space in idiopathic normal pressure hydrocephalus.Positive and negative effects of prostaglandins in Alzheimer's disease.Electroanalytical and surface plasmon resonance sensors for detection of breast cancer and Alzheimer's disease biomarkers in cells and body fluids.Biomarkers in Sporadic and Familial Alzheimer's Disease.Prevention of paraquat-induced apoptosis in human neuronal SH-SY5Y cells by lipocalin-type prostaglandin D synthase.Proteasome-caspase-cathepsin sequence leading to tau pathology induced by prostaglandin J2 in neuronal cells.Sex-Related Differences in Rat Choroid Plexus and Cerebrospinal Fluid: A cDNA Microarray and Proteomic Analysis.Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disorders A Novel Plasma Based Biomarker of Alzheimer's Disease.A G protein-coupled receptor and the intracellular synthase of its agonist functionally cooperate.Intracavitary ligand distribution in tear lipocalin by site-directed tryptophan fluorescence.Biochemical, functional, and pharmacological characterization of AT-56, an orally active and selective inhibitor of lipocalin-type prostaglandin D synthase.CsgE is a curli secretion specificity factor that prevents amyloid fibre aggregation.A novel pathway to enhance adipocyte differentiation of 3T3-L1 cells by up-regulation of lipocalin-type prostaglandin D synthase mediated by liver X receptor-activated sterol regulatory element-binding protein-1c.Cerebrospinal fluid proteomics reveals potential pathogenic changes in the brains of SIV-infected monkeys.Hippocampal neuronal cyclooxygenase-2 downstream signaling imbalance in a rat model of chronic aluminium gluconate administration.Pronounced adipogenesis and increased insulin sensitivity caused by overproduction of prostaglandin D2 in vivo.

P2860

Q24312883-3600F543-3B06-4D54-9FEC-EEBE6FEB7A4D Q24622136-D3735C53-DE5A-439C-82FC-27C2C8FAB727 Q24630614-6885516C-E4E9-42FB-95F6-021E1DEE24A1 Q27643949-543296B3-1EE5-45F1-A5B3-6E3356CBCEB1 Q27655012-FA8C720D-9E79-41F8-B776-168774B1D779 Q27694692-B0ECA6E1-F688-46CD-B4AB-678F48BA8CB1 Q28279676-34F04EEC-8CEC-4C5F-A632-EE14C4FFDE88 Q28506812-2E9160C4-E440-447A-9334-E78D953B441C Q28743561-6A1652FC-E4DE-41D4-98DB-FFE9895D6163 Q34153484-F2798094-228F-4888-AE91-E12348953BFF Q34508284-4A1A11D7-1BE1-4A17-A981-1B38DB9305F8 Q34634623-B51FC605-8BF8-4F52-8057-8921A60E00E5 Q34671631-897734CA-CA18-4E95-81F4-A34E91DB0A4C Q34933261-5A38D278-4833-41B4-A0A3-2738177C1DC7 Q34960461-EF5799AB-52FD-48BF-BA03-E11F0B2D200F Q35842012-EC1DCCDF-494B-41C7-8DE2-31D9281C4D75 Q37144717-7E5699D1-ED24-49B6-AE67-5FBA7CDC66A1 Q37157835-77C64D16-5DFF-4BEF-82BE-DFD9D714C8FB Q37175261-3FB14B53-A62C-471E-996E-C8190E8D7F14 Q37232866-8CDEB6C7-158F-4637-A68D-CC0D4C624567 Q37269299-C0DB72F6-BF68-491C-8355-F94FDC52DF33 Q37518246-56714B9E-D6E4-4AD4-9730-56527FEC3B88 Q37678539-27454025-86BB-4302-9C5A-1B303927E489 Q37710507-F746674E-5208-4DE5-B6FE-E6EAD790C50E Q38132922-0AC6377D-CE37-4BFA-98F2-ACF36DD924E6 Q38193833-A1DBABE3-68DD-45F0-BFE9-C68EC81DFE82 Q38592041-6D0A0793-E715-45EF-B1D1-2BE34ADC4BE2 Q39449759-989270EF-728F-4A3F-8C5F-4495CE935C7F Q39849130-7FC47170-4FA1-4CE0-BD0B-994CA0F160B9 Q40275476-388D3101-87C5-4BA3-9F15-8D19C36198B6 Q40663824-8E8DBC0F-1D5C-4EE6-8C25-3A6A2E0301BC Q41325603-F0137516-6C89-4257-B88A-FBB992945B4B Q41910497-C82ADAAE-97D8-4C3C-99B8-7DAF43593EB6 Q42576079-E3A50C76-96B2-47C1-A2DE-3DEA2D0B65AF Q42581400-183A4FE0-2EA9-4DF1-8C8D-9AE04505FFDA Q42795210-AC49AB92-661B-46DC-8EF3-851607D5B173 Q42829127-242638CA-7A54-4288-BCD1-14514E51383B Q42979507-B19F8171-435A-406B-843C-8CB08B05FDCE Q43157877-1771CB38-DB76-46D5-B717-322958740A2E Q43171502-87B6D87F-2608-49E3-93E9-69D56718C0CE

P2860

Lipocalin-type prostaglandin D synthase/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid.

http://www.wikidata.org/entity/Q35748577

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Lipocalin-type prostaglandin D ...... in human cerebrospinal fluid.

@ast

Lipocalin-type prostaglandin D ...... in human cerebrospinal fluid.

@en

type

label

Lipocalin-type prostaglandin D ...... in human cerebrospinal fluid.

@ast

Lipocalin-type prostaglandin D ...... in human cerebrospinal fluid.

@en

prefLabel

Lipocalin-type prostaglandin D ...... in human cerebrospinal fluid.

@ast

Lipocalin-type prostaglandin D ...... in human cerebrospinal fluid.

@en

P1433

Q35748577-D8A8919A-6346-4380-B26E-726B8E3A0EE9

P1476

Q35748577-3E540751-64E9-4348-915F-83DFA280430E

P2093

Q35748577-07E463A7-7CB6-4266-84CF-1A9125B95F5E

Q35748577-2DD8B3B4-B638-488F-95D7-4DF5CF6E3789

Q35748577-44C4A47B-6C0A-4ED5-9B90-AD8F5671701B

Q35748577-46A9A541-BF2C-46D3-99DB-15A79369BCA2

Q35748577-5017F0BD-E06C-4B6D-A518-52FD55E97B10

Q35748577-56EA7B9A-770C-40FC-9B0C-B8A20D1E9221

Q35748577-6816273D-9E75-4C16-ADAC-ECE006FC499A

Q35748577-7FBD23AF-E77A-4292-BB96-CD6B898C3F96

Q35748577-C3F66E83-58A3-4B92-8B6C-70FFF3F21BBF

Q35748577-F3E0664A-759C-44A5-B172-EE2ECAA996C2

P2860

Q35748577-01E51D90-C8E5-4DCC-AD0D-AB08DB5A6CE8

Q35748577-0622FDCE-A4A3-43F2-9983-4417D163D0F4

Q35748577-0C33EAB8-768E-4507-B89A-237434B21DAC

Q35748577-137E5B9B-9670-4E65-BA77-86DF6B8A5B09

Q35748577-18588DAD-CD0A-4C49-9017-D05A56BF43BB

Q35748577-227660ED-C653-408B-B6E2-AEF2B5B48109

Q35748577-23169EEA-AECC-46F5-963C-CF5CC16BA06A

Q35748577-2AB31644-E049-4414-83A3-D91D51902E2F

Q35748577-31001CB8-864D-4E63-9DCF-C8C674330DCB

Q35748577-32CCF452-52E0-4955-B296-1DF7E130262E

P304

Q35748577-69418A9B-CC38-4CA0-AE0B-674FF083455D

P31

Q35748577-09F331AB-0519-4559-9F92-ADF70678C9A2

P356

Q35748577-8FB588E9-30BF-4DB2-9D93-9DC2B915C9C0

P407

Q35748577-9F9F0EC9-7E6E-457A-921F-1745F1984F3A

P433

Q35748577-E4365FF0-B265-49CE-84DB-5BF219A34D65

P478

Q35748577-688B7134-E29A-4E91-A4B1-5364D87131A9

P50

Q35748577-AF0202D3-36F5-438A-99B2-0F2E8B1868DE

P577

Q35748577-237C6971-AD84-4FB1-A525-37AA582F2AEE

P5875

Q35748577-CB10C29B-98AF-4AB5-B8C8-54291A1B13C1

P698

Q35748577-E4459910-3F5D-490B-AC4B-E89FDDDBF85A

P921

Q35748577-57D89B8E-07EF-4A1D-9EC8-EDE737F4451C

Q35748577-7D3836EC-A907-4787-AA05-5C57903EF98F

P932

Q35748577-4963145F-AE14-453C-AA5F-9F2708187385

P356

PNAS.0701585104

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Lipocalin-type prostaglandin D ...... e in human cerebrospinal fluid

@en

P2093

Ikuko Mohri

http://www.w3.org/2001/XMLSchema#string

Issay Okazaki

http://www.w3.org/2001/XMLSchema#string

Keiichi Ozono

http://www.w3.org/2001/XMLSchema#string

Kosuke Aritake

http://www.w3.org/2001/XMLSchema#string

Masako Taniike

http://www.w3.org/2001/XMLSchema#string

Shigeo Murayama

http://www.w3.org/2001/XMLSchema#string

Tadato Ban

http://www.w3.org/2001/XMLSchema#string

Takahisa Kanekiyo

http://www.w3.org/2001/XMLSchema#string

Wei-Min Qu

http://www.w3.org/2001/XMLSchema#string

Yoshihiro Urade

http://www.w3.org/2001/XMLSchema#string

P2860

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

Prostaglandin D synthase gene is involved in the regulation of non-rapid eye movement sleep

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Alzheimer's disease: genes, proteins, and therapy

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR

Binding of biliverdin, bilirubin, and thyroid hormones to lipocalin-type prostaglandin D synthase

Structural and functional significance of cysteine residues of glutathione-independent prostaglandin D synthase. Identification of Cys65 as an essential thiol

Cellular localization of lipocalin-type prostaglandin D synthase (beta-trace) in the central nervous system of the adult rat

Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase.

P304

6412-6417

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0701585104

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51385742

http://www.w3.org/2001/XMLSchema#string

P698

17404210

http://www.w3.org/2001/XMLSchema#string

P921

molecular chaperones

cerebrospinal fluid

P932

1851035

http://www.w3.org/2001/XMLSchema#string